Pulmozyme Nebulizer Solution 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Pulmozyme: Nebulizer solution (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Pulmozyme 1mg/ml Soln for Inh
Drug Image file default-drug-image.png
Pulmozyme 1mg/ml Soln for Inh

What is this Medicine?

DORNASE ALFA (DOOR nace AL fa) breaks up lung congestion in patients with cystic fibrosis. It is used to improve how well the lungs work. This medicine also decreases the risk of getting a lung infection.

CVS Pharmacy Patient Statistics for Pulmozyme: Nebulizer solution(1mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Pulmozyme 1mg/ml Solution for Inhalation

NDC: 502420100
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Cystic Fibrosis, Mucolysis

Sometimes used for but not FDA approved for the following conditions:
Atelectasis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Store in original container
Pulmozyme 1mg/ml Solution for Inhalation

Reported Side Effects for Pulmozyme 1mg/ml Solution for Inhalation

Conjunctivitis Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Antibody Formation Incidence:
2.0-4.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Inflamed Vocal Cords Incidence:
3.0-4.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.0-10.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.0-36.0%*
Severity: MILD
Onset: EARLY
Hoarseness Incidence:
12.0-18.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
17.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
18.0-25.0%*
Severity: MODERATE
Onset: EARLY
Rhinitis Incidence:
27.0-35.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
30.0-45.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
32.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
32.0-40.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Pulmozyme

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5